Autoimmunity and NMDA receptor in brain disorders: Where do we stand? Daniel Hunter, Syn2Psy ESR6, is the first author of a review recently published on the journal Neurobiology of Disease, on autoimmunity and NMDA receptor in brain disorders. Abstract: Over the past decades, the identification of autoimmune encephalitis in which patients express autoantibodies directed against […]
Category: News
Marcos’ results posted on BioRxiv
Marcos Sintes, Syn2Psy ESR5, is one of the authors of a study recently posted as preprint on BioRxiv, on the potential effects of psilocybin for the therapy of autism spectrum disorder (ASD). The autors used valproic acid-exposed mice as a model of ASD and assessed the effects of the naturally occurring psychedelic prodrug psilocybin. They […]